B2M and breast cancer: These results suggest that β2M silencing upregulates p-CREB/CREB and VEGF protein and significantly downregulates p-ERK/ERK levels, but does not affect HIF-1α protein and p-SGK1/SGK1 levels in ER− breast cancer cells with HER2−.